Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2.
about
Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.Antioxidant modulation in restoring mitochondrial function in neurodegeneration.Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease.Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array.
P2860
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Cerebellar and pyramidal dysfu ...... presenting symptoms of PARK-2.
@en
Cerebellar and pyramidal dysfu ...... presenting symptoms of PARK-2.
@nl
type
label
Cerebellar and pyramidal dysfu ...... presenting symptoms of PARK-2.
@en
Cerebellar and pyramidal dysfu ...... presenting symptoms of PARK-2.
@nl
prefLabel
Cerebellar and pyramidal dysfu ...... presenting symptoms of PARK-2.
@en
Cerebellar and pyramidal dysfu ...... presenting symptoms of PARK-2.
@nl
P2093
P50
P356
P1433
P1476
Cerebellar and pyramidal dysfu ...... presenting symptoms of PARK-2.
@en
P2093
Andrea Varrone
Antonio Federico
Autilia Cozzolino
Barbara Garavaglia
Simona Gambelli
P2860
P304
P356
10.1002/MDS.22342
P407
P577
2009-01-01T00:00:00Z